BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 21570214)

  • 21. Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes?
    Guckenberger M; Richter A; Krieger T; Wilbert J; Baier K; Flentje M
    Radiother Oncol; 2009 Nov; 93(2):259-65. PubMed ID: 19748146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.
    Ost P; Speleers B; De Meerleer G; De Neve W; Fonteyne V; Villeirs G; De Gersem W
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):920-6. PubMed ID: 20675077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose escalation in prostate cancer using intensity modulated neutron radiotherapy.
    Snyder M; Joiner MC; Konski A; Bossenberger T; Burmeister J
    Radiother Oncol; 2011 May; 99(2):201-6. PubMed ID: 21620496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An improved distance-to-dose correlation for predicting bladder and rectum dose-volumes in knowledge-based VMAT planning for prostate cancer.
    Wall PDH; Carver RL; Fontenot JD
    Phys Med Biol; 2018 Jan; 63(1):015035. PubMed ID: 29131812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
    Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
    Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetric effect of photon beam energy on volumetric modulated arc therapy treatment plan quality due to body habitus in advanced prostate cancer.
    Stanley DN; Popp T; Ha CS; Swanson GP; Eng TY; Papanikolaou N; Gutiérrez AN
    Pract Radiat Oncol; 2015; 5(6):e625-33. PubMed ID: 26419443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single Arc Volumetric Modulated Arc Therapy of head and neck cancer.
    Bertelsen A; Hansen CR; Johansen J; Brink C
    Radiother Oncol; 2010 May; 95(2):142-8. PubMed ID: 20188427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helical tomotherapy versus single-arc intensity-modulated arc therapy: a collaborative dosimetric comparison between two institutions.
    Rong Y; Tang G; Welsh JS; Mohiuddin MM; Paliwal B; Yu CX
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):284-96. PubMed ID: 21236598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a Varian Clinac operated without a flattening filter.
    Vassiliev ON; Kry SF; Kuban DA; Salehpour M; Mohan R; Titt U
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1567-71. PubMed ID: 17544596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric comparison of RapidPlan and manually optimized plans in volumetric modulated arc therapy for prostate cancer.
    Kubo K; Monzen H; Ishii K; Tamura M; Kawamorita R; Sumida I; Mizuno H; Nishimura Y
    Phys Med; 2017 Dec; 44():199-204. PubMed ID: 28705507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RapidArc volumetric modulated therapy planning for prostate cancer patients.
    Kjaer-Kristoffersen F; Ohlhues L; Medin J; Korreman S
    Acta Oncol; 2009; 48(2):227-32. PubMed ID: 18855157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fully automated volumetric modulated arc therapy plan generation for prostate cancer patients.
    Voet PW; Dirkx ML; Breedveld S; Al-Mamgani A; Incrocci L; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1175-9. PubMed ID: 24529714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.
    Yuan L; Ge Y; Lee WR; Yin FF; Kirkpatrick JP; Wu QJ
    Med Phys; 2012 Nov; 39(11):6868-78. PubMed ID: 23127079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer.
    Hysing LB; Skorpen TN; Alber M; Fjellsbø LB; Helle SI; Muren LP
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1496-503. PubMed ID: 18538493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Data-driven approach to generating achievable dose-volume histogram objectives in intensity-modulated radiotherapy planning.
    Wu B; Ricchetti F; Sanguineti G; Kazhdan M; Simari P; Jacques R; Taylor R; McNutt T
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1241-7. PubMed ID: 20800382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volumetric modulated Arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic boost: a planning comparison study.
    Shaffer R; Morris WJ; Moiseenko V; Welsh M; Crumley C; Nakano S; Schmuland M; Pickles T; Otto K
    Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):401-7. PubMed ID: 19268554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of anatomy-based, fluence-based and aperture-based treatment planning approaches for VMAT.
    Rao M; Cao D; Chen F; Ye J; Mehta V; Wong T; Shepard D
    Phys Med Biol; 2010 Nov; 55(21):6475-90. PubMed ID: 20959688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated volumetric modulated arc therapy planning for whole pelvic prostate radiotherapy.
    Buschmann M; Sharfo AWM; Penninkhof J; Seppenwoolde Y; Goldner G; Georg D; Breedveld S; Heijmen BJM
    Strahlenther Onkol; 2018 Apr; 194(4):333-342. PubMed ID: 29270648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiation.
    Han C; Schultheisss TE; Wong JY
    Radiother Oncol; 2012 Feb; 102(2):315-20. PubMed ID: 21724284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.